Form 10-K
BIOTELEMETRY, INC. filed this Form 10-K on 02/22/2019
Document Outline
Entire Document (7508 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - UNITED STATES
Page 2 - BioTelemetry, Inc.
Page 3 - weourusBioTelemetryCompany
Page 4 - PART I
Page 5 - Business Strategy
Page 6 - Research
Page 7 - Other Businesses
Page 8 - Afib
Page 9 - CSRC
Page 10 - Competition
Page 11 - Intellectual Property
Page 12 - Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm.
Page 13 - ACA
Page 14 - IDTFs
Page 15 - OECD
Page 16 - Item 1A. Risk Factors
Page 17 - Our operations and our interactions with our physicians and patients are subject to regulation aimed
Page 18 - Failure to appropriately track and report certain payments to physicians and teaching hospitals may
Page 19 - Our cardiac monitoring and INR testing businesses are dependent upon physicians prescribing our serv
Page 20 - Violation of federal and state laws regarding privacy and security of patient information may advers
Page 21 - HHSOCR
Page 22 - The healthcare industry is the subject of numerous governmental investigations into marketing and ot
Page 23 - If we do not obtain and maintain adequate protection for our intellectual property, it may adversely
Page 24 - Our ability to innovate or market our products may be impaired by the intellectual property rights o
Page 25 - Any due diligence by us in connection with an acquisition may not reveal all relevant considerations
Page 26 - The success of our business is partially dependent on our ability to raise capital, and failure to r
Page 27 - Our financing costs may be adversely affected by changes in LIBOR.
Page 28 - Our business may be impacted by political events, war, terrorism, public health issues, natural disa
Page 29 - We operate in an intensely competitive industry, and our failure to respond quickly to technological
Page 30 - Changes in the health care industry or tort reform could reduce the number of cardiac monitoring sol
Page 31 - If we or our suppliers fail to achieve or maintain regulatory approval of manufacturing facilities,
Page 32 - Our products may in the future be subject to product recalls that could harm our reputation and prod
Page 33 - GenevaItem 7: Management s Discussion and Analysis of Financial Condition - Recent Developments,Earn
Page 34 - IRCSection 382
Page 35 - Item 3. Legal Proceedings
Page 36 - PART II
Page 37 - Comparison of 5 Year Cumulative Total Return
Page 38 - Item 7. Management s Discussion and Analysis of Financial Condition and Results of Operations Item 8
Page 39 - N/A
Page 40 - Item 7. Management s Discussion and Analysis of Financial Condition and Results of Operations
Page 41 - Critical Accounting Policies and Estimates
Page 42 - Stock-Based Compensation
Page 43 - Employee Share-Based Payment Accounting,
Page 44 - Income Taxes
Page 45 - Statements of Operations Overview
Page 46 - General and Administrative
Page 47 - Loss on Extinguishment of Debt
Page 48 - Gross Profit
Page 49 - Research and Development Expense
Page 50 - Income Taxes
Page 51 - General and Administrative Expense
Page 52 - Research and Development Expense
Page 53 - Income Taxes
Page 54 - Part II; Item 8. Financial Statements and Supplementary Data; Notes to Consolidated Financial Statem
Page 55 - Contractual Obligations and Commitments
Page 56 - Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Page 57 - Item 8. Financial Statements and Supplementary Data
Page 58 - BIOTELEMETRY, INC.
Page 59 - BIOTELEMETRY, INC.
Page 60 - BIOTELEMETRY, INC.
Page 61 - BIOTELEMETRY, INC.
Page 62 - BIOTELEMETRY, INC.
Page 63 - BIOTELEMETRY, INC.
Page 64 - BIOTELEMETRY, INC.
Page 65 - BIOTELEMETRY, INC.
Page 66 - BIOTELEMETRY, INC.
Page 67 - BIOTELEMETRY, INC.
Page 68 - BIOTELEMETRY, INC.
Page 69 - BIOTELEMETRY, INC.
Page 70 - BIOTELEMETRY, INC.
Page 71 - BIOTELEMETRY, INC.
Page 72 - BIOTELEMETRY, INC.
Page 73 - BIOTELEMETRY, INC.
Page 74 - BIOTELEMETRY, INC.
Page 75 - BIOTELEMETRY, INC.
Page 76 - BIOTELEMETRY, INC.
Page 77 - BIOTELEMETRY, INC.
Page 78 - BIOTELEMETRY, INC.
Page 79 - BIOTELEMETRY, INC.
Page 80 - BIOTELEMETRY, INC.
Page 81 - BIOTELEMETRY, INC.
Page 82 - BIOTELEMETRY, INC.
Page 83 - BIOTELEMETRY, INC.
Page 84 - BIOTELEMETRY, INC.
Page 85 - BIOTELEMETRY, INC.
Page 86 - BIOTELEMETRY, INC.
Page 87 - BIOTELEMETRY, INC.
Page 88 - BIOTELEMETRY, INC.
Page 89 - BIOTELEMETRY, INC.
Page 90 - BIOTELEMETRY, INC.
Page 91 - BIOTELEMETRY, INC.
Page 92 - BIOTELEMETRY, INC.
Page 93 - BIOTELEMETRY, INC.
Page 94 - BIOTELEMETRY, INC.
Page 95 - BIOTELEMETRY, INC.
Page 96 - BIOTELEMETRY, INC.
Page 97 - BIOTELEMETRY, INC.
Page 98 - BIOTELEMETRY, INC.
Page 99 - BIOTELEMETRY, INC.
Page 100 - BIOTELEMETRY, INC.
Page 101 - BIOTELEMETRY, INC.
Page 102 - BIOTELEMETRY, INC.
Page 103 - BIOTELEMETRY, INC.
Page 104 - BIOTELEMETRY, INC.
Page 105 - BIOTELEMETRY, INC.
Page 106 - BIOTELEMETRY, INC.
Page 107 - Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Page 108 - MANAGEMENT S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Page 109 - Report of Independent Registered Public Accounting Firm
Page 110 - N/A
Page 111 - Item 9B. Other Information
Page 112 - PART III
Page 113 - PART IV
Page 114 - Item 16. Form 10-K Summary
Page 115 - EXHIBIT INDEX
Page 116 - N/A
Page 117 - SIGNATURES
Subdocument 2 - EX-10.13 - EXHIBIT 10.13
Page 1 - Exhibit 10.13
Page 2 - Agreement
Page 3 - transition bonus of CHF 450 000
Page 4 - Non-Compete
Page 5 - N/A
Page 6 - N/A
Subdocument 3 - EX-21 - EXHIBIT 21
Page 1 - N/A
Subdocument 4 - EX-23 - EXHIBIT 23
Page 1 - Exhibit 23
Page 2 - N/A
Page 3 - N/A
Subdocument 5 - EX-31.1 - EXHIBIT 31.1
Page 1 - N/A
Subdocument 6 - EX-31.2 - EXHIBIT 31.2
Page 1 - N/A
Subdocument 7 - EX-32 - EXHIBIT 32
Page 1 - N/A
Subdocument - EX-101.INS - XBRL INSTANCE DOCUMENT
Subdocument - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
Subdocument - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
Subdocument - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
Subdocument - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Subdocument - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
Subdocument - XBRL Viewer


STOCK QUOTE
BEAT (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$50.43
Change (%) Stock is Up 1.37 (2.79%)
Volume81,955
Data as of 05/21/19
10:39 a.m. ET
Minimum 20 minute delay
Refresh quote

EMAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © BioTelemetry, Inc. 2013, All Rights Reserved